Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)Ended earlyNCT06873789
What this trial is testing

Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid TumorsMetastatic Solid Tumors
Incyte Corporation 9
Post-approval studies (Phase 4)Not Yet RecruitingNCT06824792
What this trial is testing

Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System

Who this might be right for
Advanced Solid Tumors
NING LI 3,000
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Early research (Phase 1)Ended earlyNCT06302140
What this trial is testing

A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers

Who this might be right for
Advanced Cancer
Viracta Therapeutics, Inc. 8
Early research (Phase 1)Study completedNCT01970540
What this trial is testing

Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors

Who this might be right for
Endometrial AdenocarcinomasNeuroendocrine TumorsSmall-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy
PharmaMar 122
Early research (Phase 1)Study completedNCT01970553
What this trial is testing

Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors

Who this might be right for
Specific Advanced Solid Tumors
PharmaMar 47
Large-scale testing (Phase 3)Active Not RecruitingNCT05347134
What this trial is testing

SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 254
Not applicableLooking for participantsNCT07552402
What this trial is testing

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

Who this might be right for
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Harbin Medical University 150
Early research (Phase 1)Study completedNCT02528357
What this trial is testing

GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)

Who this might be right for
Neoplasms
GlaxoSmithKline 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT03282344
What this trial is testing

NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SARCOMA
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)Study completedNCT03861793
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)

Who this might be right for
Advanced Solid Tumors
Mural Oncology, Inc 116
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT05438420
What this trial is testing

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerHepatocellular Cancer+1 more
Qurient Co., Ltd. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06382142
What this trial is testing

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)

Who this might be right for
Triple-Negative Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 418
Post-approval studies (Phase 4)Study completedNCT03444766
What this trial is testing

Study of Nivolumab for Advanced Cancers in India

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Non-Small-Cell Lung CarcinomaNonsmall Cell Lung Cancer+4 more
Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07418931
What this trial is testing

Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung Cancer

Who this might be right for
Advanced Squamous Non-Small Cell Lung Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 108
Testing effectiveness (Phase 2)Study completedNCT02299141
What this trial is testing

Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT01633541
What this trial is testing

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

Who this might be right for
Laryngeal Cancer
University of Michigan Rogel Cancer Center 55
Large-scale testing (Phase 3)Looking for participantsNCT07722494
What this trial is testing

IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Innovent Biologics (Suzhou) Co. Ltd. 550
Next Page